These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

218 related items for PubMed ID: 32349731

  • 1. Ten years with biosimilar rhGH in clinical practice in Sweden - experience from the prospective PATRO children and adult studies.
    Lundberg E, Kriström B, Zouater H, Deleskog A, Höybye C.
    BMC Endocr Disord; 2020 Apr 29; 20(1):55. PubMed ID: 32349731
    [Abstract] [Full Text] [Related]

  • 2. Safety and Effectiveness of Omnitrope®, a Biosimilar Recombinant Human Growth Hormone: More Than 10 Years' Experience from the PATRO Children Study.
    Pfäffle R, Bidlingmaier M, Kreitschmann-Andermahr I, Land C, Partsch CJ, Schwab KO, Sommer H, Backeljauw P, Kanumakala S, Loche S, Zouater H, Strasburger CJ.
    Horm Res Paediatr; 2020 Apr 29; 93(3):154-163. PubMed ID: 32814319
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Safety and Effectiveness of a Biosimilar Recombinant Human Growth Hormone in Children Requiring Growth Hormone Treatment: Analysis of Final Data from PATRO Children, an International, Post-Marketing Surveillance Study.
    Loche S, Kanumakala S, Backeljauw P, Schwab KO, Lechuga-Sancho AM, Esmael A, Urosevic D, Boldea A, Zabransky M.
    Drug Des Devel Ther; 2024 Apr 29; 18():667-684. PubMed ID: 38454934
    [Abstract] [Full Text] [Related]

  • 5. Safety and effectiveness of Omnitrope® (somatropin) in PATRO Children: a multi-center, post-marketing surveillance study comparison of US and international cohort data.
    Backeljauw P, Kanumakala S, Loche S, Schwab KO, Miller BS, Levy R, McCormick K, Zouater H, Zabransky M, Campbell K.
    Eur J Pediatr; 2022 Jun 29; 181(6):2367-2378. PubMed ID: 35275291
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. PATRO children, a multi-center, non-interventional study of the safety and effectiveness of Omnitrope® (somatropin) treatment in children: update on the United States cohort.
    Backeljauw P, Miller BS, Levy R, McCormick K, Zouater H, Zabransky M, Campbell K.
    J Pediatr Endocrinol Metab; 2021 Apr 27; 34(4):431-440. PubMed ID: 33647196
    [Abstract] [Full Text] [Related]

  • 9. No increased risk of glucose metabolism disorders in adults with growth hormone deficiency undergoing long-term treatment with biosimilar somatropin (Omnitrope®): data from an observational, longitudinal study.
    Beck-Peccoz P, Höybye C, Murray RD, Simsek S, Zabransky M, Zouater H, Stalla G.
    BMC Endocr Disord; 2019 Dec 11; 19(1):138. PubMed ID: 31829160
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Adherence to treatment in children with growth hormone deficiency, small for gestational age and Turner syndrome in Mexico: results of the Easypod™ connect observational study (ECOS).
    Blanco-López A, Antillón-Ferreira C, Saavedra-Castillo E, Barrientos-Pérez M, Rivero-Escalante H, Flores-Caloca O, Calzada-León R, Rosas-Guerra CC, Koledova E, Chiquete E, Ayala-Estrada A.
    J Endocrinol Invest; 2020 Oct 11; 43(10):1447-1452. PubMed ID: 32239476
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. A follow-up study to monitor adult height among Spanish children with growth hormone deficiency who received biosimilar human recombinant growth hormone (Omnitrope®) during a phase III clinical trial.
    Borrás Pérez V, López-Siguero JP, Martínez G, Corripio R, Fernández JM, Labarta JI, Ferrer M, Cabrinety N, Prieto P, Ramón-Krauel M, Bosch J, Espino R, Palla Garcia M, Rebollo FJ.
    Adv Ther; 2015 Feb 11; 32(2):148-56. PubMed ID: 25667132
    [Abstract] [Full Text] [Related]

  • 19. Predictors and growth consequences of central hypothyroidism in pediatric patients receiving recombinant human growth hormone.
    Wong K, Levitsky LL, Misra M.
    J Pediatr Endocrinol Metab; 2010 May 11; 23(5):451-61. PubMed ID: 20662344
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.